Boehringer Ingelheim Presents New Phase III Data Evaluating Linagliptin in ... - PR Newswire (press release) PDF Print
PR Newswire (press release)(2) In addition, new pharmacokinetic (PK) data demonstrate that decreases in renal function had minor effect on the elimination of linagliptin. ...New phase III data further support the safety and efficacy profile of

... read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.